Investor Presentaiton

12 Trustworthy Partner of MNCs Diversified R&D System Forward-looking Globalization Global network with overseas subsidiaries and VC funds >20yrs domestic industrial experiences with complete clinical registration and commercialization system as well as financial, legal and other capabilities Trustworthy partner with numerous collaborations Quick access to cutting-edge fields and technologies through collaboration Reached dozens of international collaborations with well-known MNCs INTUITIVE SURGICAL Kite A GILEAD Company BIONTECH AMGEN® Entered into a distribution partnership with Intuitive Surgical through subsidiary Chindex Medical, brought da Vinci Surgical System to China Announced to found JV Intuitive Fosun with Intuitive Surgical in September 2016 to further collaborate in technology, manufacturing and services Founded JV Fosun Kite with Kite Pharma in 2017 to build the leading cell therapy platform in China Yi Kai Da is the first CAR-T therapy approved in China. FKC889 for MCL is in the clinical stage in China Collaborated with BioNTech to develop and commercialize mRNA Covid-19 vaccine in China in March 2020 Sales over 30 million doses in Hong Kong, Macau and Taiwan region by the end of June 2022 Entered into the collaboration and license agreement with Amgen for the exclusive right to commercialize OtezlaⓇ and ParsabivⓇ in Chinese Mainland to strengthen non-oncology product pipeline Commercialization capability recognized by MNC, exploring new collaboration in innovative medicines

View entire presentation